ArticleCureus2026
Mixed Germ Cell Tumour in a 58-Year-Old Post-menopausal Woman: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mixed germ cell tumours (GCTs) are a rare pathology, particularly those comprising yolk sac tumour (YST) and mature cystic teratomas. Although one important biomarker for YSTs is alpha-fetoprotein (AFP), which is often characteristically elevated, this may not be the case in a minority of cases. Additionally, AFP is not usually elevated in mixed GCTs, more so in cases involving mature cystic teratoma, even with YST as a component of the tumour, as seen in the index patient who had a normal AFB value of 5 ng/mL (normal: 0-10 ng/mL). Furthermore, in postmenopausal women with stage 1 mixed GCTs, the preferred treatment is non-fertility-sparing surgery without chemotherapy. Despite the generally poor prognosis for GCTs in this demographic, early detection and treatment can lead to favourable outcomes. This report details a case of a 58-year-old woman with a stage 1 mixed GCT who underwent extensive surgery without chemotherapy and has remained tumour-free for 24 months, attributing her good prognosis to the low stage and early intervention, along with the YST component.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.